NCT07806838
Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Start date changed from estimate of Sep 10, 2026 to Oct 22, 2026
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Secondary (18)
Show 13 moreShow less
Arms and interventions
Participants will continue their prescribed GLP-1 medication and routine clinical management under the direction of their treating healthcare provider. The study will not determine GLP-1 medication selection, dosing, dose adjustments, or clinical management. Participants will receive standardized dietary/calorie and physical activity guidance and will complete the same study assessments and follow-up visits as participants in the intervention groups. They will not receive the study protein supplement, spice capsules, or placebo capsules.
Participants will receive protein supplementation with a goal of total protein intake of 1.2 g/kg lean body mass per day, based on baseline lean body mass measured by DEXA, plus placebo capsules containing 4 g of maltodextrin daily for 6 months. Participants will also receive standardized dietary/calorie and physical activity guidance.
Participants will receive protein supplementation with a goal of total protein intake of 1.2 g/kg lean body mass per day, based on baseline lean body mass measured by DEXA, plus 4 g of mixed spice capsules daily for 6 months. The daily spice mixture contains 1.0 g turmeric, 1.5 g cinnamon, 0.5 g oregano, 0.5 g black pepper, 0.3 g sage, and 0.2 g thyme. Participants will also receive standardized dietary/calorie and physical activity guidance.
Dietary supplements: Whey Protein Supplementation, Maltodextrin Placebo Capsules, Mixed Spice Capsules
Sites
1 site in 1 country
- UCLA Center for Human NutritionLos Angeles, California, United States